← Open Payments lookup

MATTHEW MACLEAN: Open Payments

NPI 1972224491 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$584 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $32 · 2025 $584

Food & beverage: $584
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$144
Novo Nordisk Inc5$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$82
Dexcom, Inc.5$81
ABBVIE INC.2$34
Ardelyx, Inc.1$28
Otsuka America Pharmaceutical, Inc.1$26
PFIZER INC.1$24
GlaxoSmithKline, LLC.1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$17

Products named: XIFAXAN, Dexcom G6 Transmitter, Rybelsus, FARXIGA, AIRSUPRA, Wegovy, BREZTRI, WAINUA.

Industry payments across VA — which companies pay providers there.